secwatch.observer — SEC 8-K summary
======================================

Issuer:     ZIMMER BIOMET HOLDINGS, INC. (ZBH)
CIK:        0001136869
Form:       8-K
Filed at:   2025-10-07T23:59:59+00:00
Accession:  0001193125-25-233473
Event type: m_and_a
Sentiment:  positive
Materiality: 0.85
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zimmer Biomet completes acquisition of Monogram Technologies for $4.04/sh plus CVRs up to $12.37
--------------------------------------------------------------------------------

- Each Monogram common share converted to $4.04 cash and non-tradeable CVRs worth up to $12.37 upon milestone achievement.
- Acquisition adds AI-driven semi- and fully autonomous robotics for TKA; FDA 510(k) clearance March 2025, commercialization expected early 2027.
- Zimmer Biomet now offers broadest orthopedic robotics portfolio including ROSA platform; nearing 2,000 installations worldwide.
- Monogram shares ceased trading on NASDAQ and will be delisted as of October 7, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1136869/000119312525233473/0001193125-25-233473-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1136869/000119312525233473/d938765d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-233473

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer